Fever after 4th shot milder than after 3rd
![](https://japannews.yomiuri.co.jp/wp-content/uploads/2022/10/vaccine1009.jpg)
Vaccines developed by Pfizer Inc.
17:01 JST, October 9, 2022
One in four people develop a fever of 37.5 C or higher following a fourth shot of Pfizer Inc.’s coronavirus vaccine, according to an interim report by a team from Juntendo University and other institutions.
However, the frequency of major side effects tends to be lower compared with those following a third inoculation. The team reported their findings Friday to an expert panel of the Health, Labor and Welfare Ministry.
Of 1,490 health care workers and others who received a fourth Pfizer shot, 26% registered a fever of 37.5 C or higher within a week, while 14% had a fever of 38 C or higher.
The interim report says 40% of people logged a fever of 37.5 C or higher after a third shot of the vaccine, while 21% saw the mercury rise to 38 C or higher. The percentage of people who developed a fever tended to be lower following the fourth inoculation.
The team also examined the effects of a fourth dose of the vaccine made by U.S. firm Moderna Inc. Of 690 patients, 39% had a fever of 37.5 C or higher, while 22% experienced temperatures of 38 C or more.
As with the Pfizer product, the percentage of those who developed a fever tended to be lower after a third shot of the Moderna vaccine.
"Society" POPULAR ARTICLE
-
Japan Court OKs Sex Change without Surgery
-
3 Climbers Die On Mt. Fuji Within 2 Days Of Opening; Japan Police, Guides Urge Climbers To Prepare Well, Make Wise Decisions
-
Sex Crime Perpetrators Linked to U.S. Military in 166 Cases in Japan over 35 years; Local, Prefectural Governments Often Not Aware of Crimes
-
New Mt. Fuji Rules Reduce ‘Bullet Climbers’ by 90%; Access to Japan’s Iconic Peak Limited from Yamanashi Pref. Side
-
Tokaido Shinkansen Trains Suspended Between Hamamatsu and Nagoya Due to Accident; Resuming Services Expected Noon at Earliest
JN ACCESS RANKING